Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 28

Results For "ASH"

3641 News Found

Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business
People | June 04, 2026

Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business

Juneja brings more than three decades of experience in pharmaceutical sales and marketing


Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business
People | June 03, 2026

Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business

Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region


Eurofragance and MartiDerm launch free skincare line to tackle 'fish odor syndrome'
News | June 03, 2026

Eurofragance and MartiDerm launch free skincare line to tackle 'fish odor syndrome'

At the center of the project is a new cosmetics line developed through collaboration between industry and medicine


FDA fast-tracks Roche’s giredestrant review as data signal potential shift in early breast cancer care
Drug Approval | June 03, 2026

FDA fast-tracks Roche’s giredestrant review as data signal potential shift in early breast cancer care

The filing is backed by Phase III data from the lidERA Breast Cancer study


Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types
Clinical Trials | June 03, 2026

Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types

The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials


Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6
News | June 03, 2026

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept


Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial
Clinical Trials | June 02, 2026

Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial

An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary


CellCarta and Leica Biosystems expand push to streamline precision medicine development
News | June 02, 2026

CellCarta and Leica Biosystems expand push to streamline precision medicine development

The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments


Ebola vax on the anvil?
News | June 02, 2026

Ebola vax on the anvil?

CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate


Hyderabad gets new 'Oval' fertility hub
News | June 02, 2026

Hyderabad gets new 'Oval' fertility hub

Fertility platform launches flagship clinic with advanced IVF tech